| Abstract Scope |
Due to COVID-19 pandemic, there is a huge surge in research developing various antiviral technologies to combat deadly pathogens. Emerging viruses are a constant threat due to the substantial variation in viral structures, and the complexity of targeting diverse viral species. In particular, the high transmissibility and infectivity of respiratory viruses have been brought to the general public’s attention, along with the need for highly effective antiviral and disinfectant materials/products. Nanotechnology have played a vital role in addressing current viral threats, from mRNA-based vaccines to nanoparticle-based drugs and nanotechnology-based disinfection. In this presentation, we will provide a summary focused on key design considerations for high-efficacy antiviral nanomaterials and various modes of biological activity. Insights into potential future research directions are also provided specifically to the SARS-CoV2 virus. An example of metal modified ceria nanostructures and its high efficacy for use against clinically relevant virus species is presented. |